ArticleFrontiers in nutrition2026
Association between pre-operative computed tomography-based adipose tissue quantification and post-transplant dyslipidemia in renal transplantation recipients.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is an established correlation between obesity and dyslipidemia in individuals who have undergone kidney transplantation (KT). Body composition is a more accurate indicator of obesity than body mass index (BMI). However, the relationship between pre-operative body composition and post-transplant dyslipidemia remains unexplored. Methods: We analyzed 333 participants who underwent KT between 2021 and 2024. Using pre-transplantation computed tomography (CT), we assessed the cross-sectional areas of skeletal muscle (SM) and adipose tissue at the level of the third lumbar vertebra. Participants were categorized into high and low body composition groups based on the highest quartile, and into dyslipidemia and non-dyslipidemia groups according to post-transplant blood lipid levels. Skeletal muscle (SM) and adipose tissue metrics were subsequently used to model dyslipidemia after KT. Generalized estimating equations (GEE) were then employed to assess the impact of body composition on blood lipid levels at 45 days, and at 3, 6 months, and 1 year post-transplant. Results: Univariate analysis revealed that BMI ( Conclusions: High pre-transplant VAT was associated with low HDL-C, elevated TG, and LDL-C levels after KT. These findings may have significant implications for reducing the incidence of dyslipidemia post-KT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.